Successful gene therapy for the respiratory manifestations of cystic fibrosis (CF) requires efficient transfer of the normal cystic fibrosis transmembrane conductance regulator (CFTR) cDNA to the airway epithelium in sufficient amount, distribution and persistence to correct the deficiency of CFTR function that characterizes the airway abnormalities in this disorder. Replication deficient, recombinant adenovirus (Ad) vectors based on group C Ad backbones have many advantages as gene transfer vectors to achieve this goal, but the vectors in their present form are not capable of providing persistent, high level correction of the deficiency of CFTR function in the airway epithelium. Based on the concept that the interaction of Ad vectors with the epithelium and many of the host responses to Ad vectors are dependent on specific epitopes in the Ad capsid (fiber, penton base, and/or hexon), this project is focused on understanding the biologic processes related to the unidirectional trafficking from cell surface to nucleus demonstrated by Ad vectors with modified capsid components interacting with airway epithelial cells. The underlying thesis of this project is that an understanding of how the Ad translocates within the cell, and how Ad serotypes and chimeric Ad vectors differ in this process, will help in designing gene transfer vectors that can reach the target cell nucleus of differentiated airway epithelium with maximum efficiency. The crux of the studies will be to evaluate the intracellular biologic processes associated with translocation of the Ad vector prior to the time the Ad vector genome is transcribed by the target cell. This project has three specific aims: (1) To examine the hypothesis that the kinetics of the Ad binding, entry, intracellular translocation, nuclear binding and/or the fate of the capsid can be modified by altering individual components of the Ad capsid; (2) To evaluate the hypothesis that Ad virions are actively transported to the nucleus along cytoskeleton elements; and (3) To assess the hypothesis that the Ad capsomere contains nuclear envelope targeting information.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051746-07
Application #
6318389
Study Section
Project Start
2000-06-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
7
Fiscal Year
2000
Total Cost
$252,599
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Ryan, Dorothy M; Vincent, Thomas L; Salit, Jacqueline et al. (2014) Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 9:e88051
Dvorak, Anna; Tilley, Ann E; Shaykhiev, Renat et al. (2011) Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol 44:465-73
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Limberis, Maria P; Bell, Christie L; Heath, Jack et al. (2010) Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18:143-50
Song, Yuhu; Lou, Howard H; Boyer, Julie L et al. (2009) Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 20:267-81
Vandenberghe, L H; Breous, E; Nam, H-J et al. (2009) Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther 16:1416-28
Fein, David E; Limberis, Maria P; Maloney, Sean F et al. (2009) Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung. Mol Ther 17:2078-87
Limberis, Maria P; Vandenberghe, Luk H; Zhang, Liqun et al. (2009) Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 17:294-301
Tertilt, Christine; Joh, Ju; Krause, Anja et al. (2009) Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 77:3044-55
Limberis, M P; Bell, C L; Wilson, J M (2009) Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 16:441-7

Showing the most recent 10 out of 85 publications